Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk

ClinicalTrials.gov ID: NCT00447187

Public ClinicalTrials.gov record NCT00447187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Placebo-Controlled, Randomized, Parallel Group, Dose-Ranging Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure Following Penetrating Keratoplasty With LX201 Implantation in Subjects Who Are at Increased Immunological Risk

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a pivotal trial to determine whether LX201 reduces the likelihood of a graft rejection episode following corneal transplantation in patients at high immunological risk for rejection.

Study identification

NCT ID
NCT00447187
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lux Biosciences, Inc.
Industry
Enrollment
368 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2007 (Type not available)
Primary completion
Mar 2009 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Oct 11, 2012

2007 – 2010

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
Cornea Consultants of Arizona Phoenix Arizona 85032 —
Loma Linda University Health Care Loma Linda California 92354 —
USC Doheny Eye Institute Los Angeles California 90033 —
Bascom Palmer Eye Institute Miami Florida 33136 —
Emory Eye Center Atlanta Georgia 30322 —
University of Illinois at Chicago Chicago Illinois 60612 —
Price Vision Group Indianapolis Indiana 46260 —
The Eye Center at Union Memorial Hospital Baltimore Maryland 21218 —
Wilmer Eye Institute, Cornea Service Baltimore Maryland 21287 —
New England Eye Center Boston Massachusetts 02111 —
W.K. Kellogg Eye Center - University of Michigan Ann Arbor Michigan 48105 —
MN Eye Consultants, P.A. Bloomington Minnesota 55431 —
Tauber Eye Center Kansas City Missouri 64111 —
Ophthalmology Associates St Louis Missouri 63141 —
UMDNJ - New Jersey Medical School Institute of Ophthalmology and Visual Science Newark New Jersey 07103 —
New York Eye and Ear Infirmary New York New York 10003 —
Mount Sinai School of Medicine New York New York 10029 —
Ophthalmic Consultants of Long Island Rockville Centre New York 11570 —
Cornea Consultants of Albany Slingerlands New York 12159 —
Duke University Eye Center Durham North Carolina 27705 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Cornea Associates of Texas Dallas Texas 75231 —
Virginia Eye Consultants Norfolk Virginia 23502 —
Eye Associates NW Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00447187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2012 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00447187 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →